ES2133686T3 - Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2133686T3
ES2133686T3 ES95401607T ES95401607T ES2133686T3 ES 2133686 T3 ES2133686 T3 ES 2133686T3 ES 95401607 T ES95401607 T ES 95401607T ES 95401607 T ES95401607 T ES 95401607T ES 2133686 T3 ES2133686 T3 ES 2133686T3
Authority
ES
Spain
Prior art keywords
sub
pharmaceutical compositions
compositions containing
preparation procedure
benzopyran derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95401607T
Other languages
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Mark Millan
Adrian Newman-Tancredi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2133686T3 publication Critical patent/ES2133686T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESTOS DE FORMULA (I) EN LA QUE N REPRESENTA 1 O 2, R{SUB,1} REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALKILO, BENCILO, ACETILO, BENZOILO ,ALILO, PIRIDINOCARBONILO, PIRIDINOMETILO, ACILAMINOALKILO EVENTUALMENTE SUSTITUIDO, PIRIDINOAMINOCARBONILO, FTALIMIDOALKILO, TIOCROMANILOXIALKILO O BENZODIOXANILOXIALKILO, R{SUB,2}, R{SUB,3} O R{SUB,4} IDENTICOS O DIFERENTES REPRESENTAN UN ATOMO DE HIDROGENO, DE HALOGENO O UN GRUPO ALKILO, ALCOXI, HIDROXI, ACETILO, AMINOCARBONILO, AMINOMETILO, CIANO, NITRO, AMINO, FENILO, (SUSTITUIDO O NO) FURILO, PIRIDILO, TIENILO O PIRROLILO O R{SUB,2}, R{SUB,3} CUANDO ESTAN SITUADOS SOBRE CARBONOS ADYACENTES FORMAN CON LOS ATOMOS DE CARBONO QUE LOS LLEVAN UN NUCLEO FURANO O FENILO, SUS ISOMEROS ASI COMO SUS SALES DE ADICION A UN ACIDO FARMACEUTICAMENTE ACEPTABLE. MEDICAMENTOS.
ES95401607T 1994-07-06 1995-07-05 Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2133686T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408328A FR2722194B1 (fr) 1994-07-06 1994-07-06 Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2133686T3 true ES2133686T3 (es) 1999-09-16

Family

ID=9465049

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95401607T Expired - Lifetime ES2133686T3 (es) 1994-07-06 1995-07-05 Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (16)

Country Link
US (2) US5663191A (es)
EP (1) EP0691342B1 (es)
JP (1) JP2999139B2 (es)
CN (1) CN1049660C (es)
AT (1) ATE179421T1 (es)
AU (1) AU684165B2 (es)
CA (1) CA2153195C (es)
DE (1) DE69509308T2 (es)
DK (1) DK0691342T3 (es)
ES (1) ES2133686T3 (es)
FI (1) FI111945B (es)
FR (1) FR2722194B1 (es)
GR (1) GR3030168T3 (es)
NO (1) NO311085B1 (es)
NZ (1) NZ272501A (es)
ZA (1) ZA955631B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891882A (en) * 1996-12-06 1999-04-06 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
FR2823752B1 (fr) * 2001-04-18 2004-10-22 Servier Lab Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0118892D0 (en) * 2001-08-02 2001-09-26 Vernalis Res Ltd Method of treatment
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
JP2008530229A (ja) * 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
DE602007004111D1 (de) * 2006-04-03 2010-02-11 Hoffmann La Roche Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
TW200924752A (en) * 2007-09-17 2009-06-16 Organon Nv Tricyclic heterocyclic derivatives
WO2010069793A1 (en) * 2008-12-16 2010-06-24 F. Hoffmann-La Roche Ag Process for the preparation of pyrollidine-3-carboxylic acids
FR2948372B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN105111220A (zh) * 2015-09-12 2015-12-02 浙江大学 取代1,4-二氢苯并吡喃[2,3-b]吡咯化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518272A (en) * 1968-02-05 1970-06-30 Warner Lambert Pharmaceutical Tetrahydro benzopyranoquinolines and process for their production
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
EP0422134B1 (en) * 1988-12-15 1996-06-12 Abbott Laboratories 5-ht selective agents
GB8917333D0 (en) * 1989-07-28 1989-09-13 Merck Sharp & Dohme Therapeutic agents
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0691342B1 (fr) 1999-04-28
CA2153195A1 (fr) 1996-01-07
US5663191A (en) 1997-09-02
GR3030168T3 (en) 1999-08-31
ATE179421T1 (de) 1999-05-15
NO952660L (no) 1996-01-08
FI953308A7 (fi) 1996-01-07
DE69509308D1 (de) 1999-06-02
US5723484A (en) 1998-03-03
FR2722194B1 (fr) 1996-08-23
CN1119189A (zh) 1996-03-27
NO952660D0 (no) 1995-07-05
DK0691342T3 (da) 1999-11-08
ZA955631B (en) 1996-02-16
DE69509308T2 (de) 1999-11-25
AU2482695A (en) 1996-01-18
NO311085B1 (no) 2001-10-08
NZ272501A (en) 1996-03-26
FR2722194A1 (fr) 1996-01-12
EP0691342A1 (fr) 1996-01-10
AU684165B2 (en) 1997-12-04
FI111945B (fi) 2003-10-15
JPH0841066A (ja) 1996-02-13
FI953308A0 (fi) 1995-07-05
CA2153195C (fr) 2004-06-15
CN1049660C (zh) 2000-02-23
JP2999139B2 (ja) 2000-01-17

Similar Documents

Publication Publication Date Title
ES2134755T3 (es) Derivados de quinolina como antagonistas de leucotrieno d4, composiciones que contienen los mismos y procedimientos para su preparacion.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
AR027437A1 (es) Derivados de purina
MX9300786A (es) Compuestos hipolipidaemicos.
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2159922T3 (es) Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2098505T3 (es) Nuevos derivados de la talidomida, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2162404T3 (es) Nuevos derivados del indol y del indazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2153457T3 (es) Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2182090T3 (es) Nuevos derivados de pirrol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 691342

Country of ref document: ES